SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-047830
Filing Date
2015-08-10
Accepted
2015-08-10 17:03:26
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v416949_10q.htm 10-Q 360338
2 EXHIBIT 31.1 v416949_ex31-1.htm EX-31.1 8541
3 EXHBITI 32.1 v416949_ex32-1.htm EX-32.1 4400
  Complete submission text file 0001144204-15-047830.txt   3590484

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20150630.xml EX-101.INS 653007
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20150630.xsd EX-101.SCH 48420
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20150630_cal.xml EX-101.CAL 37189
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20150630_def.xml EX-101.DEF 276953
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20150630_lab.xml EX-101.LAB 326492
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20150630_pre.xml EX-101.PRE 305696
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 151041565
SIC: 2834 Pharmaceutical Preparations